Merit Medical Systems (MMSI) Earnings: 1Q Adjusted EPS Surpasses Expectations with Strong Revenue Growth

Merit Medical Systems on Smartkarma

Independent analysts on Smartkarma, like Baptista Research, have been providing bullish coverage on Merit Medical Systems. According to Baptista Research, Merit Medical Systems reported strong financial performance in the fourth quarter of 2024, with significant revenue and profit growth. The company surpassed its growth expectations, achieving a total revenue of $355.2 million in Q4, reflecting a 9% increase year-over-year on a GAAP basis and 10% on a constant currency basis.

In another report by Baptista Research, they highlighted 7 major game-changers impacting Merit Medical Systems‘ 2025 performance and beyond. The company’s third-quarter financial results for 2024 showed a revenue increase, reaching $339.8 million with a year-over-year growth of 7.8% on a GAAP basis and 7.9% on a constant currency basis, surpassing their projected growth range. This positive sentiment from analysts underscores the company’s promising performance and potential for future growth.

A look at Merit Medical Systems Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Merit Medical Systems, Inc. has received a mixed bag of Smart Scores according to Smartkarma’s analysis. While the company scored high in terms of Growth and Momentum with scores of 4 each, indicating a promising long-term potential for expansion and positive market traction, it scored lower in Value and Dividend with scores of 2 and 1 respectively. This suggests that investors may find better value and dividend opportunities elsewhere. The Resilience score of 3 positions the company in a moderate range in terms of its ability to withstand economic fluctuations. Overall, Merit Medical Systems seems to have a bright outlook for growth and momentum, but investors should consider other factors for a comprehensive investment decision.

Merit Medical Systems, Inc. specializes in manufacturing and selling products used in diagnostic and interventional cardiology and radiology procedures worldwide. Their product range includes inflation devices, guide wires, thrombolytic catheters, fluid dispensing systems, and angiography accessories among others. With a focus on innovation and a global presence, Merit Medical Systems plays a significant role in the healthcare industry. The company’s high scores in Growth and Momentum indicate a strong potential for future development and market performance, positioning it well for long-term success in the medical devices sector.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma